SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q4 EPS of ($0.28), $0.06 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $21.7 million versus the consensus estimate of $20.49 million.

GUIDANCE:

SOPHiA GENETICS SA sees FY2026 revenue of $92-94 million, versus the consensus of $88.65 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.